Showing results (1-10 of 29) with videos related to
Sort By:
Pageof 3
The British Journal of Psychiatry : the Journal of Mental Science|August 1, 1997
Cost-effectiveness of clozapine. A UK clinic-based studyK J Aitchison, R W KerwinPsychological Medicine|February 14, 2009
Extracting a needle from a haystack: reanalysis of whole genome data reveals a readily translatable findingR Keers, A E Farmer, K J AitchisonDrug Metabolism and Drug Interactions|May 23, 2000
The relevance of ethnic influences on pharmacogenetics to the treatment of psychosisK J Aitchison, B D Jordan, T SharmaJournal of Psychopharmacology (Oxford, England)|December 17, 2008
Housekeeping gene expression is affected by antidepressant treatment in a mouse fibroblast cell lineK Sugden, C M Pariante, P McGuffin, et al.European Psychiatry : the Journal of the Association of European Psychiatrists|May 14, 2010
The genetics of affective disorder and suicideP McGuffin, N Perroud, R Uher, et al.Biological Psychiatry|March 12, 1998
Apolipoprotein E: depressive illness, depressive symptoms, and Alzheimer's diseaseC Holmes, C Russ, G Kirov, et al.Pharmacogenetics|March 30, 2000
Association study of dopamine receptor gene polymorphisms with drug-induced hallucinations in patients with idiopathic Parkinson's diseaseA J Makoff, J M Graham, M J Arranz, et al.Schizophrenia Research|August 26, 1998
Case-control, haplotype relative risk and transmission disequilibrium analysis of a dopamine D2 receptor functional promoter polymorphism in schizophreniaT Li, M Arranz, K J Aitchison, et al.Journal of Psychopharmacology (Oxford, England)|June 11, 2008
Interrater reliability of the Antipsychotic Non-Neurological Side-Effects Rating Scale measured in patients treated with clozapineR I Ohlsen, R Williamson, B Yusufi, et al.Journal of Psychopharmacology (Oxford, England)|February 24, 2001
Clozapine pharmacokinetics and pharmacodynamics studied with Cyp1A2-null miceK J Aitchison, M W Jann, J H Zhao, et al.Pageof 3